The Evolving Paradigm of Melanoma Treatment

Janice Mehnert, MD, reviews recent developments in Melanoma treatments, specifically Adjuvant and Neoadjuvant landscapes. Dr. Mehnert identifies a selection of targeted therapys versus immunotherapy, and also describes the management of brain metastases.

Back to Symposium Page »


March 20, 2021

Created by

Scripps CME Connection

Related Presenters

Janice Mehnert, MD

Janice Mehnert, MD

Associate Director, Clinical Research
Laura and Isaac Perlmutter Cancer Center at NYU
Disease Management Group Leader
Melanoma and Cutaneous Oncology NYU Langone Health

Dr. Janice Mehnert is a nationally recognized expert in early phase therapeutics and the treatment of skin malignancies, is  the Associate Director for clinical researchat Perlmutter Cancer and Director, Melanoma and Cutaneous Medical ...

View full profile